# A Study of Inclisiran in Participants With Renal Impairment Compared to Participants With Normal Renal Function (ORION-7)

> **NCT03159416** · PHASE1 · COMPLETED · sponsor: **The Medicines Company** · enrollment: 31 (actual)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** Inclisiran

## Key facts

- **NCT ID:** NCT03159416
- **Lead sponsor:** The Medicines Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-22
- **Primary completion:** 2018-03-24
- **Final completion:** 2018-03-24
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03159416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03159416, "A Study of Inclisiran in Participants With Renal Impairment Compared to Participants With Normal Renal Function (ORION-7)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03159416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*